Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S., M.R.C.G.P.
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Consultant Physician
MBBS, DFM (Family Medicine), MCPS (Family Medicine), MRCGP (International), Diploma in Diabetes
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P. (UK)*
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., MCPS (Medicine)
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Diabetologist
MBBS, Post Graduate Diploma In Diabetes (DIP)
Consultant Physician
MBBS, FCPS (Medicine), MCPS (Family Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures